Spirit Small Vessel Registry (SPIRIT SV).

Trial Profile

Spirit Small Vessel Registry (SPIRIT SV).

Phase of Trial: Phase III

Latest Information Update: 01 May 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Atherosclerosis; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms SPIRIT SV
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 31 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 May 2012 Planned End Date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top